Reported Jul 12, 2023 · Ongoing
Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC:…
Preferred Pharmaceuticals, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Preferred Pharmaceuticals, Inc. · 1250 N Lakeview Ave Ste O · Anaheim, CA · 92807-1801
Is this the product you have?
- Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2)
- b)30-count bottles (NDC
68788-7781-3)c) 60-count bottles(NDC: 68788-7781-6)
- d) 90-count bottles (NDC68788-7781-9)
- e) 120-count bottles (NDC68788-7781-8), Rx only
- MfgDr. Reddy's Laboratories Limited
- Lot codes and dates
- Lot#: a) H1621S
- Exp
12/31/2023b) H2321C
- Exp
12/31/2023c) H0421B
- Exp
12/31/2023d) H1721EH1921TH3121M
- Exp
12/31/2023e) H2021G
- Exp12/31/2023
- Amount recalled
- 541 Bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Stability Specifications
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Preferred Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.